Class I lysine deacetylases promote glucocorticoid-induced transcriptional repression through functional interaction with LSD1

Nina M. Patrick, Chanel A. Griggs, Ali L. Icenogle, Maryam M. Gilpatrick, Vineela Kadiyala, Rosa Jaime-Frias, Catharine Smith

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Small molecule inhibitors of lysine deacetylases (KDACs) are approved for clinical use in treatment of several diseases. Nuclear receptors, such as the glucocorticoid receptor (GR) use lysine acetyltransferases (KATs or HATs) and KDACs to regulate transcription through acetylation and deacetylation of protein targets such as histones. Previously we have shown that KDAC1 activity facilitates GR-activated transcription at about half of all cellular target genes. In the current study we examine the role of Class I KDACs in glucocorticoid-mediated repression of gene expression. Inhibition of KDACs through two structurally distinct Class I-selective inhibitors prevented dexamethasone (Dex)-mediated transcriptional repression in a gene-selective fashion. In addition, KDAC activity is also necessary to maintain repression. Steroid receptor coactivator 2 (SRC2), which is known to play a vital role in GR-mediated repression of pro-inflammatory genes, was found to be dispensable for repression of glucocorticoid target genes sensitive to KDAC inhibition. At the promoters of these genes, KDAC inhibition did not result in altered nucleosome occupancy or histone H3 acetylation. Surprisingly, KDAC inhibition rapidly induced a significant decrease in H3K4Me2 at promoter nucleosomes with no corresponding change in H3K4Me3, suggesting the activation of the lysine demethylase, LSD1/KDM1A. Depletion of LSD1 expression via siRNA restored Dex-mediated repression in the presence of KDAC inhibitors, suggesting that LSD1 activation at these gene promoters is incompatible with transcriptional repression. Treatment with KDAC inhibitors does not alter cellular levels of LSD1 or its association with Dex-repressed gene promoters. Therefore, we conclude that Class I KDACs facilitate Dex-induced transcriptional repression by suppressing LSD1 complex activity at selected target gene promoters. Rather than facilitating repression of transcription, LSD1 opposes it in these gene contexts.

Original languageEnglish (US)
Pages (from-to)1-13
Number of pages13
JournalJournal of Steroid Biochemistry and Molecular Biology
Volume167
DOIs
StatePublished - Mar 1 2017

Fingerprint

Glucocorticoids
Lysine
Genes
Dexamethasone
Glucocorticoid Receptors
Transcription
Nucleosomes
Acetylation
Histones
Nuclear Receptor Coactivator 2
Chemical activation
Acetyltransferases
Cytoplasmic and Nuclear Receptors
Small Interfering RNA
Transcriptional Activation
Gene expression
Gene Expression
Association reactions
Molecules
Proteins

Keywords

  • Glucocorticoid
  • Lysine deacetylase
  • Lysine demethylase
  • Repression
  • Transcription

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)
  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Endocrinology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Class I lysine deacetylases promote glucocorticoid-induced transcriptional repression through functional interaction with LSD1. / Patrick, Nina M.; Griggs, Chanel A.; Icenogle, Ali L.; Gilpatrick, Maryam M.; Kadiyala, Vineela; Jaime-Frias, Rosa; Smith, Catharine.

In: Journal of Steroid Biochemistry and Molecular Biology, Vol. 167, 01.03.2017, p. 1-13.

Research output: Contribution to journalArticle

Patrick, Nina M. ; Griggs, Chanel A. ; Icenogle, Ali L. ; Gilpatrick, Maryam M. ; Kadiyala, Vineela ; Jaime-Frias, Rosa ; Smith, Catharine. / Class I lysine deacetylases promote glucocorticoid-induced transcriptional repression through functional interaction with LSD1. In: Journal of Steroid Biochemistry and Molecular Biology. 2017 ; Vol. 167. pp. 1-13.
@article{488a62eab43b4777bc74f778eaef62a6,
title = "Class I lysine deacetylases promote glucocorticoid-induced transcriptional repression through functional interaction with LSD1",
abstract = "Small molecule inhibitors of lysine deacetylases (KDACs) are approved for clinical use in treatment of several diseases. Nuclear receptors, such as the glucocorticoid receptor (GR) use lysine acetyltransferases (KATs or HATs) and KDACs to regulate transcription through acetylation and deacetylation of protein targets such as histones. Previously we have shown that KDAC1 activity facilitates GR-activated transcription at about half of all cellular target genes. In the current study we examine the role of Class I KDACs in glucocorticoid-mediated repression of gene expression. Inhibition of KDACs through two structurally distinct Class I-selective inhibitors prevented dexamethasone (Dex)-mediated transcriptional repression in a gene-selective fashion. In addition, KDAC activity is also necessary to maintain repression. Steroid receptor coactivator 2 (SRC2), which is known to play a vital role in GR-mediated repression of pro-inflammatory genes, was found to be dispensable for repression of glucocorticoid target genes sensitive to KDAC inhibition. At the promoters of these genes, KDAC inhibition did not result in altered nucleosome occupancy or histone H3 acetylation. Surprisingly, KDAC inhibition rapidly induced a significant decrease in H3K4Me2 at promoter nucleosomes with no corresponding change in H3K4Me3, suggesting the activation of the lysine demethylase, LSD1/KDM1A. Depletion of LSD1 expression via siRNA restored Dex-mediated repression in the presence of KDAC inhibitors, suggesting that LSD1 activation at these gene promoters is incompatible with transcriptional repression. Treatment with KDAC inhibitors does not alter cellular levels of LSD1 or its association with Dex-repressed gene promoters. Therefore, we conclude that Class I KDACs facilitate Dex-induced transcriptional repression by suppressing LSD1 complex activity at selected target gene promoters. Rather than facilitating repression of transcription, LSD1 opposes it in these gene contexts.",
keywords = "Glucocorticoid, Lysine deacetylase, Lysine demethylase, Repression, Transcription",
author = "Patrick, {Nina M.} and Griggs, {Chanel A.} and Icenogle, {Ali L.} and Gilpatrick, {Maryam M.} and Vineela Kadiyala and Rosa Jaime-Frias and Catharine Smith",
year = "2017",
month = "3",
day = "1",
doi = "10.1016/j.jsbmb.2016.09.014",
language = "English (US)",
volume = "167",
pages = "1--13",
journal = "Journal of Steroid Biochemistry and Molecular Biology",
issn = "0960-0760",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Class I lysine deacetylases promote glucocorticoid-induced transcriptional repression through functional interaction with LSD1

AU - Patrick, Nina M.

AU - Griggs, Chanel A.

AU - Icenogle, Ali L.

AU - Gilpatrick, Maryam M.

AU - Kadiyala, Vineela

AU - Jaime-Frias, Rosa

AU - Smith, Catharine

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Small molecule inhibitors of lysine deacetylases (KDACs) are approved for clinical use in treatment of several diseases. Nuclear receptors, such as the glucocorticoid receptor (GR) use lysine acetyltransferases (KATs or HATs) and KDACs to regulate transcription through acetylation and deacetylation of protein targets such as histones. Previously we have shown that KDAC1 activity facilitates GR-activated transcription at about half of all cellular target genes. In the current study we examine the role of Class I KDACs in glucocorticoid-mediated repression of gene expression. Inhibition of KDACs through two structurally distinct Class I-selective inhibitors prevented dexamethasone (Dex)-mediated transcriptional repression in a gene-selective fashion. In addition, KDAC activity is also necessary to maintain repression. Steroid receptor coactivator 2 (SRC2), which is known to play a vital role in GR-mediated repression of pro-inflammatory genes, was found to be dispensable for repression of glucocorticoid target genes sensitive to KDAC inhibition. At the promoters of these genes, KDAC inhibition did not result in altered nucleosome occupancy or histone H3 acetylation. Surprisingly, KDAC inhibition rapidly induced a significant decrease in H3K4Me2 at promoter nucleosomes with no corresponding change in H3K4Me3, suggesting the activation of the lysine demethylase, LSD1/KDM1A. Depletion of LSD1 expression via siRNA restored Dex-mediated repression in the presence of KDAC inhibitors, suggesting that LSD1 activation at these gene promoters is incompatible with transcriptional repression. Treatment with KDAC inhibitors does not alter cellular levels of LSD1 or its association with Dex-repressed gene promoters. Therefore, we conclude that Class I KDACs facilitate Dex-induced transcriptional repression by suppressing LSD1 complex activity at selected target gene promoters. Rather than facilitating repression of transcription, LSD1 opposes it in these gene contexts.

AB - Small molecule inhibitors of lysine deacetylases (KDACs) are approved for clinical use in treatment of several diseases. Nuclear receptors, such as the glucocorticoid receptor (GR) use lysine acetyltransferases (KATs or HATs) and KDACs to regulate transcription through acetylation and deacetylation of protein targets such as histones. Previously we have shown that KDAC1 activity facilitates GR-activated transcription at about half of all cellular target genes. In the current study we examine the role of Class I KDACs in glucocorticoid-mediated repression of gene expression. Inhibition of KDACs through two structurally distinct Class I-selective inhibitors prevented dexamethasone (Dex)-mediated transcriptional repression in a gene-selective fashion. In addition, KDAC activity is also necessary to maintain repression. Steroid receptor coactivator 2 (SRC2), which is known to play a vital role in GR-mediated repression of pro-inflammatory genes, was found to be dispensable for repression of glucocorticoid target genes sensitive to KDAC inhibition. At the promoters of these genes, KDAC inhibition did not result in altered nucleosome occupancy or histone H3 acetylation. Surprisingly, KDAC inhibition rapidly induced a significant decrease in H3K4Me2 at promoter nucleosomes with no corresponding change in H3K4Me3, suggesting the activation of the lysine demethylase, LSD1/KDM1A. Depletion of LSD1 expression via siRNA restored Dex-mediated repression in the presence of KDAC inhibitors, suggesting that LSD1 activation at these gene promoters is incompatible with transcriptional repression. Treatment with KDAC inhibitors does not alter cellular levels of LSD1 or its association with Dex-repressed gene promoters. Therefore, we conclude that Class I KDACs facilitate Dex-induced transcriptional repression by suppressing LSD1 complex activity at selected target gene promoters. Rather than facilitating repression of transcription, LSD1 opposes it in these gene contexts.

KW - Glucocorticoid

KW - Lysine deacetylase

KW - Lysine demethylase

KW - Repression

KW - Transcription

UR - http://www.scopus.com/inward/record.url?scp=84994403480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994403480&partnerID=8YFLogxK

U2 - 10.1016/j.jsbmb.2016.09.014

DO - 10.1016/j.jsbmb.2016.09.014

M3 - Article

C2 - 27645313

AN - SCOPUS:84994403480

VL - 167

SP - 1

EP - 13

JO - Journal of Steroid Biochemistry and Molecular Biology

JF - Journal of Steroid Biochemistry and Molecular Biology

SN - 0960-0760

ER -